Hematology Pills
By Mattioli Health
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Mattioli Health
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 16
Description
Hematology Pills is a new format based on monthly discussions between Prof. Robin Foà (Rome) and Dr. Filippo Milano (Seattle). Each episode explores the latest breakthroughs in gene therapy, immunotherapy, and clinical innovation, while addressing also ethical and practical challenges that shape the field. Our podcast offers a clear and compelling look at the evolving landscape of blood disorders and treatments for hematologists, researchers and healthcare professionals. Stay informed, inspired, and connected with Hematology Pills – a source off hematology updates, one episode at a time.
| Episode | Date |
|---|---|
|
The Next Chapter of Cord Blood Transplantation: Harnessing Immune Responses to Improve Transplant Outcomes – A dialogue between Robin Foà and Filippo Milano
|
Jun 19, 2026 |
|
Ph+ ALL without chemotherapy: when TKIs reshape the immune response – A dialogue between Robin Foà, Filippo Milano e Michela Ansuinelli
|
May 20, 2026 |
|
AI in Hematology and Beyond: Transforming Diagnostics, Research, and Care – A dialogue between Robin Foà and Filippo Milano
|
Apr 20, 2026 |
|
Iron Biology Unveiled: Hepcidin, Erythroferrone and the Modern Understanding of Iron Metabolism – A dialogue between Robin Foà, Filippo Milano e Clara Camaschella
|
Mar 19, 2026 |
|
The Cost of Progress: Funding, Pharma, and the Future of Hematology – A dialogue between Robin Foà e Filippo Milano
|
Feb 20, 2026 |
|
From chemotherapy to targeted precision: A paradigm shift in the frontline treatment of Ph+ ALL - A dialogue between Robin Foà, Filippo Milano and Sabina Chiaretti
|
Jan 20, 2026 |
|
The New Era of CLL Therapy: From Chemo-Free Strategies to Fixed-Duration Regimens - A dialogue Between Robin Foà, Filippo Milano and Mazyar Shadman
|
Dec 03, 2025 |
|
Acute Myeloid Leukemia: Progress, Plateau, and the Path Ahead – A Dialogue Between Robin Foà, Filippo Milano and Fred Appelbaum
|
Oct 27, 2025 |
|
Ph-Positive Acute Lymphoblastic Leukemia, 25 Years of Progress – A Dialogue Between Robin Foà and Filippo Milano
|
Aug 25, 2025 |
|
Evolving Strategies in ALL: CAR-T Cells, MRD, and the Decline of Transplant – A Dialogue Between Robin Foà and Filippo Milano
|
Jul 21, 2025 |
|
Transplant as Immunotherapy: The PTCy Revolution, GVHD Control, and the New Era of Allogeneic SCT – A Dialogue Between Robin Foà and Filippo Milano
|
Jun 12, 2025 |
|
Understanding CAR-T Resistance: Biology, Persistence, and the Pathways to Failure – A Dialogue Between Robin Foà, Filippo Milano, andMarco Ruella
|
May 12, 2025 |
|
CAR-T in Multiple Myeloma: Balancing Innovation, Toxicity, and Access – A Dialogue Between Robin Foà, Filippo Milano and Rahul Banerjee
|
Apr 09, 2025 |
|
CAR-T Cells: Navigating the Landscape of Access, Sustainability, and Innovation - A Dialogue Between Robin Foà and Filippo Milano
|
Mar 11, 2025 |
|
Gene Therapy: Innovation Meets Access Challenges – A Dialogue Between Robin Foà and Filippo Milano
|
Feb 26, 2025 |
|
Hematology Pills. Insights into Gene and Immunotherapy - Teaser
|
Feb 26, 2025 |